Login / Signup

Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathies.

Guillaume LamotteCourtney HolmesPatricia SullivanAbhishek LenkaDavid S Goldstein
Published in: Annals of clinical and translational neurology (2020)
By in vivo sympathetic neuroimaging and postmortem neurochemistry peripheral noradrenergic deficiency in LB synucleinopathies is cardioselective. MSA does not involve peripheral noradrenergic deficiency.
Keyphrases
  • chemotherapy induced
  • replacement therapy
  • parkinson disease